Ausgabe 4/2019
Inhalt (20 Artikel)
SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines
Xing Chen, Dongsheng Xiong, Liya Ye, Huichun Yang, Shuangshuang Mei, Jinhong Wu, Shanshan Chen, Ruoran Mi
Blockade of integrin β3 signals to reverse the stem-like phenotype and drug resistance in melanoma
Xiaoxia Zhu, Xiaohua Tao, Wei Lu, Yang Ding, Yi Tang
Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade
Qiu-ping Jia, Chang-you Yan, Xue-rong Zheng, Xia Pan, Xin Cao, Lei Cao
Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study
Lei Gong, Weimin Mao, Qixun Chen, Youhua Jiang, Yun Fan
Encapsulation of a new quinoxaline derivative in PLGA alters the pattern of its anticancer potency and induces apoptosis
Entsar A. Saad, Heba M. Waly
Molecular targeting of HER2-overexpressing biliary tract cancer cells with trastuzumab emtansine, an antibody–cytotoxic drug conjugate
Yoriko Yamashita-Kashima, Yasushi Yoshimura, Takaaki Fujimura, Sei Shu, Mieko Yanagisawa, Keigo Yorozu, Koh Furugaki, Ryota Higuchi, Junichi Shoda, Naoki Harada
Influence of oral magnesium-containing supplement and antacid administration on hypomagnesemia induced by panitumumab
Junya Sato, Hiroshi Ishikawa, Rei Tanaka, Michihiro Sino
In vitro and in vivo anticancer effects of two quinoline–platinum(II) complexes on human osteosarcoma models
Maria Carolina Ruiz, Agustina Resasco, Ana Laura Di Virgilio, Miguel Ayala, Isabel Cavaco, Silvia Cabrera, Jose Aleman, Ignacio Esteban León
Pharmacokinetic and cytokine profiles of melanoma patients with dabrafenib and trametinib-induced pyrexia
Hannah Yejin Kim, Janna K. Duong, Maria Gonzalez, Georgina V. Long, Alexander M. Menzies, Helen Rizos, Su Yin Lim, Jenny Lee, Alan V. Boddy
Population pharmacokinetics analysis of nivolumab in Asian and non-Asian patients with gastric and gastro-esophageal junction cancers
Mayu Osawa, Mayumi Hasegawa, Akintunde Bello, Amit Roy, Matthew W. Hruska
Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer
Kathleen Moore, John K. Chan, Angeles Alvarez Secord, Manish R. Patel, Timothy Callahan, Wei Guo, Zhi-Yi Zhang
Effect of aprepitant administration on CINV caused by cisplatin multi-day chemotherapy and pharmacokinetics of docetaxel
Lin Guo, Hao Peng, Hua-Lin Cai, Dan Tang, Hao Hu, Feng Wang, Jia Liu, Kai-Lin Que, Chen Han, Ying Zhang, Miao Yan, Jin-An Ma
Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer
Osman Köstek, Erdem Yılmaz, Muhammet Bekir Hacıoğlu, Nazım Can Demircan, Ali Gökyer, Sernaz Uzunoğlu, Nermin Tunçbilek, İrfan Çiçin, Bülent Erdoğan
A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancer
M. Campone, T. Bachelot, F. Penault-Llorca, A. Pallis, V. Agrapart, M. J. Pierrat, C. Poirot, F. Dubois, L. Xuereb, C. J. Bossard, N. Guigal-Stephan, B. Lockhart, F. Andre
Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia
Al-Motassem Yousef, Rand Farhad, Daniah Alshamaseen, Abrar Alsheikh, Mohammed Zawiah, Taha Kadi
Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer
Alexander Hoemme, Holger Barth, Manuel Haschke, Stephan Krähenbühl, Florian Strasser, Claudia Lehner, Alexander von Kameke, Thomas Wälti, Beat Thürlimann, Martin Früh, Christoph Driessen, Markus Joerger
Cyclophosphamide dose adjustment based on body weight and albuminemia in elderly patients treated with R-mini-CHOP
E. Baudry, S. Huguet, A. L. Couderc, P. Chaibi, F. Bret, C. Verny, S. Weill, O. Madar, S. Urien, Keyvan Rezai
Phase I study of orally administered 14Carbon-isotope labelled-vistusertib (AZD2014), a dual TORC1/2 kinase inhibitor, to assess the absorption, metabolism, excretion, and pharmacokinetics in patients with advanced solid malignancies
Alexander MacDonald, Graeme Scarfe, Dominic Magirr, Tinnu Sarvotham, Julie Charlton, Wolfram Brugger, Emma Dean
d-dimer increase: an unfavorable factor for patients with primary liver cancer treated with TACE
Xujiao Chen, Zhihui Chang, Zhaoyu Liu
ABCB1 c.3435C>T polymorphism is associated with platinum toxicity: a preliminary study
Beatrice De Troia, Davide Dalu, Virginio Filipazzi, Luigi Isabella, Nicoletta Tosca, Sabrina Ferrario, Anna Rita Gambaro, Luisa Somma, Cinzia Fasola, Stefania Cheli, Emilio Clementi, Davide De Francesco, Felicia Stefania Falvella, Maria Teresa Cattaneo